# Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder

> **NCT05271084** · PHASE1,PHASE2 · COMPLETED · sponsor: **Hawler Medical University** · enrollment: 100 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Citalopram (tablet) 20 mg + Pentoxifylline (tablet) 400Mg
- **DRUG:** Citalopram (tablet) 20 mg + Placebo (tablet)

## Key facts

- **NCT ID:** NCT05271084
- **Lead sponsor:** Hawler Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-10
- **Primary completion:** 2022-02-25
- **Final completion:** 2022-06-08
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05271084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05271084, "Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05271084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*